{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:13:49Z","timestamp":1787948029873,"version":"build-2784847793"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Pituitary adenomas affect patients\u2019 quality-of-life (QoL) across several domains, with long-term implications even following gross-total resection or disease remission. While clinical outcomes can assess treatment efficacy, they do not capture variations in QoL. We present the development and validation of a patient reported outcome measure (PROM) for patients with pituitary adenomas undergoing transsphenoidal surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The COSMIN checklist informed the development of the pituitary outcome score (POS). Consecutive patients undergoing surgical treatment for suspected pituitary adenoma at a single centre were included prospectively. An expert focus group and patient interviews informed item generation. Item reduction was conducted through exploratory factor analysis and expert consensus, followed by assessment of the tool\u2019s validity, reliability, responsiveness, and interpretability.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>96 patients with a median age of 50\u00a0years validated the POS. The final questionnaire included 25 questions with four subscales: EQ-5D-5L-QoL, Visual Symptoms, Endocrine Symptoms and Nasal Symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The POS is the first validated PROM for patients undergoing transsphenoidal surgery for a pituitary adenoma. This PROM could be integrated into contemporary practice to provide patient-centred outcomes assessment for this patient group, aligning more closely with patient objectives.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11102-022-01251-x","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T06:02:57Z","timestamp":1657864977000},"page":"673-683","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A patient-reported outcome measure for patients with pituitary adenoma undergoing transsphenoidal surgery"],"prefix":"10.1007","volume":"25","author":[{"given":"Elika","family":"Karvandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Gerrard","family":"Hanrahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyal Zaman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Marc","family":"Boloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fion","family":"Bremner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Cabrilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Dorward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Grieve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inma","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria Anne","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelos","family":"Kolias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E.","family":"Baldeweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani Joseph","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"key":"1251_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab200","author":"QT Ostrom","year":"2021","unstructured":"Ostrom QT, Cioffi G, Waite K et al (2021) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014\u20132018. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noab200","journal-title":"Neuro Oncol"},{"key":"1251_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ecl.2020.04.002","volume":"49","author":"AF Daly","year":"2020","unstructured":"Daly AF, Beckers A (2020) The epidemiology of pituitary adenomas. Endocrinol Metab Clin North Am 49:347\u2013355","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1251_CR3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1227\/01.NEU.0000134287.19377.A2","volume":"55","author":"WT Couldwell","year":"2004","unstructured":"Couldwell WT, Weiss MH, Rabb C et al (2004) Variations on the standard transsphenoidal approach to the sellar region, with emphasis on the extended approaches and parasellar approaches: surgical experience in 105 cases. Neurosurgery 55:539\u2013550. https:\/\/doi.org\/10.1227\/01.NEU.0000134287.19377.A2","journal-title":"Neurosurgery"},{"key":"1251_CR4","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3171\/jns.2001.95.6.1083","volume":"95","author":"JK Liu","year":"2001","unstructured":"Liu JK, Das K, Weiss MH et al (2001) The history and evolution of transsphenoidal surgery. J Neurosurg 95:1083\u20131096. https:\/\/doi.org\/10.3171\/jns.2001.95.6.1083","journal-title":"J Neurosurg"},{"key":"1251_CR5","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1227\/01.NEU.0000137330.02549.0D","volume":"55","author":"P Cappabianca","year":"2004","unstructured":"Cappabianca P, Cavallo LM, de Divitiis E (2004) Endoscopic endonasal transsphenoidal surgery. Neurosurgery 55:933\u2013941. https:\/\/doi.org\/10.1227\/01.NEU.0000137330.02549.0D","journal-title":"Neurosurgery"},{"key":"1251_CR6","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1210\/jc.2013-1036","volume":"98","author":"RM Starke","year":"2013","unstructured":"Starke RM, Raper DMS, Payne SC et al (2013) Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission. J Clin Endocrinol Metab 98:3190\u20133198. https:\/\/doi.org\/10.1210\/jc.2013-1036","journal-title":"J Clin Endocrinol Metab"},{"key":"1251_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/ons\/opy078","volume":"16","author":"J Bakhsheshian","year":"2019","unstructured":"Bakhsheshian J, Wheeler S, Strickland BA et al (2019) Surgical outcomes following repeat transsphenoidal surgery for nonfunctional pituitary adenomas: a retrospective comparative study. Op Neurosurg 16:127\u2013135. https:\/\/doi.org\/10.1093\/ons\/opy078","journal-title":"Op Neurosurg"},{"key":"1251_CR8","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00701-017-3438-z","volume":"160","author":"RD Almutairi","year":"2018","unstructured":"Almutairi RD, Muskens IS, Cote DJ et al (2018) Gross total resection of pituitary adenomas after endoscopic vs. microscopic transsphenoidal surgery: a meta-analysis. Acta Neurochir 160:1005\u20131021. https:\/\/doi.org\/10.1007\/s00701-017-3438-z","journal-title":"Acta Neurochir"},{"key":"1251_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022713","volume":"99","author":"Y Morinaga","year":"2020","unstructured":"Morinaga Y, Abe I, Nii K et al (2020) Characteristics and clinical outcomes in pituitary incidentalomas and non-incidental pituitary tumors treated with endoscopic transsphenoidal surgery. Medicine 99:e22713. https:\/\/doi.org\/10.1097\/MD.0000000000022713","journal-title":"Medicine"},{"key":"1251_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1023\/B:PITU.0000004798.27230.ed","volume":"6","author":"MD Johnson","year":"2003","unstructured":"Johnson MD, Woodburn CJ, Vance ML (2003) Quality of life in patients with a pituitary adenoma. Pituitary 6:81\u201387. https:\/\/doi.org\/10.1023\/B:PITU.0000004798.27230.ed","journal-title":"Pituitary"},{"key":"1251_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13915","author":"A Vega-Beyhart","year":"2018","unstructured":"Vega-Beyhart A, Enriquez-Estrada VM, Bello-Chavolla OY et al (2018) Quality of life is significantly impaired in both secretory and non-functioning pituitary adenomas. Clin Endocrinol. https:\/\/doi.org\/10.1111\/cen.13915","journal-title":"Clin Endocrinol"},{"key":"1251_CR12","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s11102-015-0636-7","volume":"18","author":"CD Andela","year":"2015","unstructured":"Andela CD, Scharloo M, Pereira AM et al (2015) Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies. Pituitary 18:752\u2013776. https:\/\/doi.org\/10.1007\/s11102-015-0636-7","journal-title":"Pituitary"},{"key":"1251_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-59602-4.00024-1","author":"AM Pereira","year":"2014","unstructured":"Pereira AM (2014) Long-term effects of treatment of pituitary adenomas. Handb Clin Neurol. https:\/\/doi.org\/10.1016\/B978-0-444-59602-4.00024-1","journal-title":"Handb Clin Neurol"},{"key":"1251_CR14","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s11102-017-0860-4","volume":"21","author":"CD Andela","year":"2018","unstructured":"Andela CD, Lobatto DJ, Pereira AM et al (2018) How non-functioning pituitary adenomas can affect health-related quality of life: a conceptual model and literature review. Pituitary 21:208\u2013216. https:\/\/doi.org\/10.1007\/s11102-017-0860-4","journal-title":"Pituitary"},{"key":"1251_CR15","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1468-0009.2005.00397.x","volume":"83","author":"A Donabedian","year":"2005","unstructured":"Donabedian A (2005) Evaluating the quality of medical care. Milbank Q 83:691\u2013729","journal-title":"Milbank Q"},{"key":"1251_CR16","doi-asserted-by":"publisher","first-page":"f167","DOI":"10.1136\/bmj.f167","volume":"346","author":"N Black","year":"2013","unstructured":"Black N (2013) Patient reported outcome measures could help transform healthcare. BMJ 346:f167\u2013f167. https:\/\/doi.org\/10.1136\/bmj.f167","journal-title":"BMJ"},{"key":"1251_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7818","author":"EC Nelson","year":"2015","unstructured":"Nelson EC, Eftimovska E, Lind C et al (2015) Patient reported outcome measures in practice. BMJ. https:\/\/doi.org\/10.1136\/bmj.g7818","journal-title":"BMJ"},{"key":"1251_CR18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1530\/EJE-07-0762","volume":"158","author":"SM Webb","year":"2008","unstructured":"Webb SM, Badia X, Barahona MJ et al (2008) Evaluation of health-related quality of life in patients with cushing\u2019s syndrome with a new questionnaire. Eur J Endocrinol 158:623\u2013630. https:\/\/doi.org\/10.1530\/EJE-07-0762","journal-title":"Eur J Endocrinol"},{"key":"1251_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11102-014-0561-1","volume":"18","author":"CD Andela","year":"2015","unstructured":"Andela CD, Niemeijer ND, Scharloo M et al (2015) Towards a better quality of life (QoL) for patients with pituitary diseases: results from a focus group study exploring QoL. Pituitary 18:86\u2013100. https:\/\/doi.org\/10.1007\/s11102-014-0561-1","journal-title":"Pituitary"},{"key":"1251_CR20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3171\/2014.10.JNS14921","volume":"123","author":"AS Little","year":"2015","unstructured":"Little AS, Kelly DF, Milligan J et al (2015) Comparison of sinonasal quality of life and health status in patients undergoing microscopic and endoscopic transsphenoidal surgery for pituitary lesions: a prospective cohort study. J Neurosurg 123:799\u2013807. https:\/\/doi.org\/10.3171\/2014.10.JNS14921","journal-title":"J Neurosurg"},{"key":"1251_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11102-016-0707-4","volume":"19","author":"CD Andela","year":"2016","unstructured":"Andela CD, Scharloo M, Ramondt S et al (2016) The development and validation of the Leiden Bother and needs questionnaire for patients with pituitary disease: the LBNQ-pituitary. Pituitary 19:293\u2013302. https:\/\/doi.org\/10.1007\/s11102-016-0707-4","journal-title":"Pituitary"},{"key":"1251_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2147\/PROM.S156291","volume":"10","author":"J Field","year":"2019","unstructured":"Field J, Holmes MM, Newell D (2019) PROMs data: can it be used to make decisions for individual patients? A narrative review. Pat Relat Outcome Meas 10:233\u2013241. https:\/\/doi.org\/10.2147\/PROM.S156291","journal-title":"Pat Relat Outcome Meas"},{"key":"1251_CR23","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11136-010-9606-8","volume":"19","author":"LB Mokkink","year":"2010","unstructured":"Mokkink LB, Terwee CB, Patrick DL et al (2010) The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 19:539\u2013549. https:\/\/doi.org\/10.1007\/s11136-010-9606-8","journal-title":"Qual Life Res"},{"key":"1251_CR24","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s11136-018-1829-0","volume":"27","author":"CB Terwee","year":"2018","unstructured":"Terwee CB, Prinsen CAC, Chiarotto A et al (2018) COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res 27:1159\u20131170. https:\/\/doi.org\/10.1007\/s11136-018-1829-0","journal-title":"Qual Life Res"},{"key":"1251_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-10-22","author":"LB Mokkink","year":"2010","unstructured":"Mokkink LB, Terwee CB, Knol DL et al (2010) The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol. https:\/\/doi.org\/10.1186\/1471-2288-10-22","journal-title":"BMC Med Res Methodol"},{"key":"1251_CR26","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s11136-012-0322-4","volume":"22","author":"MF Janssen","year":"2013","unstructured":"Janssen MF, Pickard AS, Golicki D et al (2013) Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res 22:1717\u20131727. https:\/\/doi.org\/10.1007\/s11136-012-0322-4","journal-title":"Qual Life Res"},{"key":"1251_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/hex.12442","volume":"20","author":"B Wiering","year":"2017","unstructured":"Wiering B, de Boer D, Delnoij D (2017) Patient involvement in the development of patient-reported outcome measures: a scoping review. Health Expect 20:11\u201323. https:\/\/doi.org\/10.1111\/hex.12442","journal-title":"Health Expect"},{"key":"1251_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"J Ware","year":"1992","unstructured":"Ware J, Sherbourne C (1992) The MOS 36-ltem short-form health survey (SF-36) I. conceptual framework and item selection. Med Care 30:473\u2013483","journal-title":"Med Care"},{"key":"1251_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1179\/jmt.2009.17.3.163","volume":"17","author":"SJ Kamper","year":"2009","unstructured":"Kamper SJ, Maher CG, Mackay G (2009) Global rating of change scales: a review of strengths and weaknesses and considerations for design. J Man & Manip Ther 17:163\u2013170. https:\/\/doi.org\/10.1179\/jmt.2009.17.3.163","journal-title":"J Man & Manip Ther"},{"key":"1251_CR30","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jclinepi.2009.09.009","volume":"63","author":"SJ Kamper","year":"2010","unstructured":"Kamper SJ, Ostelo RWJG, Knol DL et al (2010) Global perceived effect scales provided reliable assessments of health transition in people with musculoskeletal disorders, but ratings are strongly influenced by current status. J Clin Epidemiol 63:760-766.e1. https:\/\/doi.org\/10.1016\/j.jclinepi.2009.09.009","journal-title":"J Clin Epidemiol"},{"key":"1251_CR31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1177\/0013164405282485","volume":"66","author":"RK Henson","year":"2006","unstructured":"Henson RK, Roberts JK (2006) Use of exploratory factor analysis in published research. Educ Psychol Measur 66:393\u2013416. https:\/\/doi.org\/10.1177\/0013164405282485","journal-title":"Educ Psychol Measur"},{"key":"1251_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5116\/ijme.4dfb.8dfd","volume":"2","author":"M Tavakol","year":"2011","unstructured":"Tavakol M, Dennick R (2011) Making sense of Cronbach\u2019s alpha. Int J Med Educ 2:53\u201355. https:\/\/doi.org\/10.5116\/ijme.4dfb.8dfd","journal-title":"Int J Med Educ"},{"key":"1251_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15:155\u2013163. https:\/\/doi.org\/10.1016\/j.jcm.2016.02.012","journal-title":"J Chiropr Med"},{"key":"1251_CR34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","volume":"305","author":"JE Brazier","year":"1992","unstructured":"Brazier JE, Harper R, Jones NM et al (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305:160\u2013164. https:\/\/doi.org\/10.1136\/bmj.305.6846.160","journal-title":"BMJ"},{"key":"1251_CR35","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.2215\/CJN.06300617","volume":"12","author":"A Ju","year":"2017","unstructured":"Ju A, Tong A (2017) Considerations and challenges in selecting patient-reported outcome measures for clinical trials in nephrology. Clin J Am Soc Nephrol 12:1882\u20131884. https:\/\/doi.org\/10.2215\/CJN.06300617","journal-title":"Clin J Am Soc Nephrol"},{"key":"1251_CR36","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/art.20179","volume":"50","author":"AM Huber","year":"2004","unstructured":"Huber AM, Feldman BM, Rennebohm RM et al (2004) Validation and clinical significance of the childhood myositis assessment scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum 50:1595\u20131603. https:\/\/doi.org\/10.1002\/art.20179","journal-title":"Arthritis Rheum"},{"key":"1251_CR37","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1471-2288-11-152","volume":"11","author":"F Angst","year":"2011","unstructured":"Angst F (2011) The new COSMIN guidelines confront traditional concepts of responsiveness. BMC Med Res Methodol 11:152. https:\/\/doi.org\/10.1186\/1471-2288-11-152","journal-title":"BMC Med Res Methodol"},{"key":"1251_CR38","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.jclinepi.2008.10.011","volume":"62","author":"CB Terwee","year":"2009","unstructured":"Terwee CB, Roorda LD, Knol DL et al (2009) Linking measurement error to minimal important change of patient-reported outcomes. J Clin Epidemiol 62:1062\u20131067. https:\/\/doi.org\/10.1016\/j.jclinepi.2008.10.011","journal-title":"J Clin Epidemiol"},{"key":"1251_CR39","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A et al (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20:1727\u20131736. https:\/\/doi.org\/10.1007\/s11136-011-9903-x","journal-title":"Qual Life Res"},{"key":"1251_CR40","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/eye.2018.1","volume":"32","author":"JM Sparrow","year":"2018","unstructured":"Sparrow JM, Grzeda MT, Frost NA et al (2018) Cat-PROM5: a brief psychometrically robust self-report questionnaire instrument for cataract surgery. Eye 32:796\u2013805. https:\/\/doi.org\/10.1038\/eye.2018.1","journal-title":"Eye"},{"key":"1251_CR41","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s11165-016-9602-2","volume":"48","author":"KS Taber","year":"2018","unstructured":"Taber KS (2018) The use of Cronbach\u2019s alpha when developing and reporting research instruments in science education. Res Sci Educ 48:1273\u20131296. https:\/\/doi.org\/10.1007\/s11165-016-9602-2","journal-title":"Res Sci Educ"},{"key":"1251_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11336-008-9101-0","volume":"74","author":"K Sijtsma","year":"2009","unstructured":"Sijtsma K (2009) On the use, the misuse, and the very limited usefulness of Cronbach\u2019s alpha. Psychometrika 74:107\u2013120. https:\/\/doi.org\/10.1007\/s11336-008-9101-0","journal-title":"Psychometrika"},{"key":"1251_CR43","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1177\/0363546508330143","volume":"37","author":"KK Briggs","year":"2009","unstructured":"Briggs KK, Lysholm J, Tegner Y et al (2009) The reliability, validity, and responsiveness of the Lysholm score and Tegner activity scale for anterior cruciate ligament injuries of the knee. Am J Sports Med 37:890\u2013897. https:\/\/doi.org\/10.1177\/0363546508330143","journal-title":"Am J Sports Med"},{"key":"1251_CR44","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1136\/bjsports-2016-096776","volume":"52","author":"KM Crossley","year":"2018","unstructured":"Crossley KM, Macri EM, Cowan SM et al (2018) The patellofemoral pain and osteoarthritis subscale of the KOOS (KOOS-PF): development and validation using the COSMIN checklist. Br J Sports Med 52:1130\u20131136. https:\/\/doi.org\/10.1136\/bjsports-2016-096776","journal-title":"Br J Sports Med"},{"key":"1251_CR45","doi-asserted-by":"publisher","first-page":"205031211667172","DOI":"10.1177\/2050312116671725","volume":"4","author":"L Lins","year":"2016","unstructured":"Lins L, Carvalho FM (2016) SF-36 total score as a single measure of health-related quality of life: scoping review. SAGE Open Med 4:205031211667172. https:\/\/doi.org\/10.1177\/2050312116671725","journal-title":"SAGE Open Med"},{"key":"1251_CR46","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.3171\/2011.1.FOCUS10319","volume":"30","author":"YY Wang","year":"2011","unstructured":"Wang YY, Srirathan V, Tirr E et al (2011) Nasal symptoms following endoscopic transsphenoidal pituitary surgery: assessment using the General Nasal Patient Inventory. Neurosurg Focus 30:E12. https:\/\/doi.org\/10.3171\/2011.1.FOCUS10319","journal-title":"Neurosurg Focus"},{"key":"1251_CR47","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1055\/s-0036-1597814","volume":"38","author":"B Davies","year":"2017","unstructured":"Davies B, Tirr E, Wang Y, Gnanalingham K (2017) Transient exacerbation of nasal symptoms following endoscopic transsphenoidal surgery for pituitary tumors: a prospective study. Journal of Neurological Surgery Part B: Skull Base 38:266\u2013272. https:\/\/doi.org\/10.1055\/s-0036-1597814","journal-title":"Journal of Neurological Surgery Part B: Skull Base"},{"key":"1251_CR48","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2004.100.5.0813","author":"Z Gil","year":"2004","unstructured":"Gil Z, Abergel A, Spektor S et al (2004) Development of a cancer-specific anterior skull base quality-of-life questionnaire. J Neurosurg. https:\/\/doi.org\/10.3171\/jns.2004.100.5.0813","journal-title":"J Neurosurg"},{"key":"1251_CR49","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1001\/archotol.129.12.1303","volume":"129","author":"Z Gil","year":"2003","unstructured":"Gil Z, Abergel A, Spektor S et al (2003) Quality of life following surgery for anterior skull base tumors. Arch Otolaryngol-Head & Neck Surg 129:1303. https:\/\/doi.org\/10.1001\/archotol.129.12.1303","journal-title":"Arch Otolaryngol-Head & Neck Surg"},{"key":"1251_CR50","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s11102-020-01106-3","volume":"24","author":"A Graf","year":"2021","unstructured":"Graf A, Marcus HJ, Baldeweg SE (2021) The direct and indirect impact of the COVID-19 pandemic on the care of patients with pituitary disease: a cross sectional study. Pituitary 24:262\u2013268. https:\/\/doi.org\/10.1007\/s11102-020-01106-3","journal-title":"Pituitary"},{"key":"1251_CR51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/0027317090279420644","volume":"44","author":"JCF de Winter","year":"2009","unstructured":"de Winter JCF, Dodou D, Wieringa PA (2009) Exploratory factor analysis with small sample sizes. Multivar Behav Res 44:147\u2013181. https:\/\/doi.org\/10.1080\/0027317090279420644","journal-title":"Multivar Behav Res"},{"key":"1251_CR52","doi-asserted-by":"publisher","first-page":"359","DOI":"10.22237\/jmasm\/1288584240","volume":"9","author":"RH Pearson","year":"2010","unstructured":"Pearson RH, Mundform DJ (2010) Recommended sample size for conducting exploratory factor analysis on dichotomous data. J Mod Appl Stat Methods 9:359\u2013368. https:\/\/doi.org\/10.22237\/jmasm\/1288584240","journal-title":"J Mod Appl Stat Methods"},{"key":"1251_CR53","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.4236\/psych.2018.98126","volume":"09","author":"TA Kyriazos","year":"2018","unstructured":"Kyriazos TA (2018) Applied psychometrics: sample size and sample power considerations in factor analysis (EFA, CFA) and SEM in general. Psychology 09:2207\u20132230. https:\/\/doi.org\/10.4236\/psych.2018.98126","journal-title":"Psychology"},{"key":"1251_CR54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1207\/s15327574ijt0502_4","volume":"5","author":"DJ Mundfrom","year":"2005","unstructured":"Mundfrom DJ, Shaw DG, Ke TL (2005) Minimum sample size recommendations for conducting factor analyses. Int J Test 5:159\u2013168. https:\/\/doi.org\/10.1207\/s15327574ijt0502_4","journal-title":"Int J Test"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01251-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-022-01251-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01251-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T10:22:14Z","timestamp":1659435734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-022-01251-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1251"],"URL":"https:\/\/doi.org\/10.1007\/s11102-022-01251-x","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]},"assertion":[{"value":"28 June 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Following discussion with the Health Research Authority, this study did not require REC approval and was registered as a service evaluation with the local governance committee of the National Hospital of Neurology and Neurosurgery (NHNN).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u00a9 EuroQol Research Foundation. EQ-5D\u2122 is a trademark of the EuroQol Research Foundation. SF-5D was reproduced by permission of EuroQol Research Foundation. Reproduction of this version is not allowed. For reproduction, use or modification of the EQ-5D (any version), please register your study by using the online EQ registration page: .","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Copyright & trademarking"}}]}}